Form D · Other Technology

TANDEM DIABETES CARE INC

San Diego, CA · CIK 0001438133

Offering snapshot reported Sep 11, 2012 · SEC filing

Reported sold
$36.4M
Offering amount: $50M
Investors reported
43
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 30, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 11, 2012Initial$36,387,925No comparison43SEC filing
Aug 18, 2011Initial$12,001,200No comparison8SEC filing
Jan 8, 2010Amendment$52,343,055$30,981,891vs May 29, 200931SEC filing
May 29, 2009Initial$21,361,164No comparisonNot reportedSEC filing
Jun 13, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-183927

Source: Form D, filed Sep 11, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dick Allen Director
Kim D. Blickenstaff Director, Executive
Ned Brown Director
Edward L. Cahill Director
John Cajigas Executive
Paul Di Perna Director
Howard E. Greene Director
Keith Grossman Director
John H. Livingston Director
Douglas A. Roeder Director
Paul Sekhri Director
Jesse Treu Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
11045 Roselle Street
San Diego, CA, 92121